MedTrace Logo

Transvaginal Treatment of Symptomatic Cystocele Grade II-III

NCT02272322 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2017-02-01

No results posted yet for this study

Summary

This observational study will evaluate treatment of symptomatic cystocele grade II-III with Cousin Biomesh and Allium Medical Endofast Reliant. Data about 100 patients will be collected. Follow-up till 3 years after the procedure. Primary endpoint is absence of recurrence.

Conditions

  • Cystocele

Interventions

DEVICE

cystocele repair with biomesh soft prolaps and endofast reliant

Sponsors & Collaborators

  • Slabbaert Koen

    lead OTHER

Principal Investigators

  • Koen Slabbaert, MD · RZ Heilig Hart Tienen

Eligibility

Min Age
40 Years
Max Age
90 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2017-12-31
Completion
2019-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02272322 on ClinicalTrials.gov